IL150285A0 - Nucleic acid vaccination - Google Patents
Nucleic acid vaccinationInfo
- Publication number
- IL150285A0 IL150285A0 IL15028500A IL15028500A IL150285A0 IL 150285 A0 IL150285 A0 IL 150285A0 IL 15028500 A IL15028500 A IL 15028500A IL 15028500 A IL15028500 A IL 15028500A IL 150285 A0 IL150285 A0 IL 150285A0
- Authority
- IL
- Israel
- Prior art keywords
- nucleic acid
- glycosylation
- acid vaccination
- isolated polynucleotide
- polypeptide
- Prior art date
Links
- 150000007523 nucleic acids Chemical class 0.000 title 1
- 102000039446 nucleic acids Human genes 0.000 title 1
- 108020004707 nucleic acids Proteins 0.000 title 1
- 238000002255 vaccination Methods 0.000 title 1
- 230000013595 glycosylation Effects 0.000 abstract 3
- 238000006206 glycosylation reaction Methods 0.000 abstract 3
- 102000040430 polynucleotide Human genes 0.000 abstract 2
- 108091033319 polynucleotide Proteins 0.000 abstract 2
- 239000002157 polynucleotide Substances 0.000 abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 101100346932 Mus musculus Muc1 gene Proteins 0.000 abstract 1
- 108700001237 Nucleic Acid-Based Vaccines Proteins 0.000 abstract 1
- 125000000539 amino acid group Chemical group 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 210000004962 mammalian cell Anatomy 0.000 abstract 1
- 239000000178 monomer Substances 0.000 abstract 1
- 229940023146 nucleic acid vaccine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001169—Tumor associated carbohydrates
- A61K39/00117—Mucins, e.g. MUC-1
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9930359.6A GB9930359D0 (en) | 1999-12-22 | 1999-12-22 | Novel polypeptides |
| PCT/GB2000/004906 WO2001046228A2 (fr) | 1999-12-22 | 2000-12-20 | Améliorations apportées à une vaccination par acide nucléique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL150285A0 true IL150285A0 (en) | 2002-12-01 |
Family
ID=10866857
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL15028500A IL150285A0 (en) | 1999-12-22 | 2000-12-20 | Nucleic acid vaccination |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US20030133909A1 (fr) |
| EP (1) | EP1240317B1 (fr) |
| JP (1) | JP2003517845A (fr) |
| KR (1) | KR20020073149A (fr) |
| CN (1) | CN1434862A (fr) |
| AT (1) | ATE355365T1 (fr) |
| AU (1) | AU2204901A (fr) |
| BR (1) | BR0016672A (fr) |
| CA (1) | CA2395208A1 (fr) |
| CZ (1) | CZ20022192A3 (fr) |
| DE (1) | DE60033690T2 (fr) |
| ES (1) | ES2282156T3 (fr) |
| GB (1) | GB9930359D0 (fr) |
| HU (1) | HUP0203848A3 (fr) |
| IL (1) | IL150285A0 (fr) |
| MX (1) | MXPA02006313A (fr) |
| NO (1) | NO20023010L (fr) |
| NZ (1) | NZ519732A (fr) |
| PL (1) | PL356697A1 (fr) |
| WO (1) | WO2001046228A2 (fr) |
| ZA (1) | ZA200204987B (fr) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0212046D0 (en) * | 2002-05-24 | 2002-07-03 | Glaxo Group Ltd | Vaccines |
| GB0212036D0 (en) * | 2002-05-24 | 2002-07-03 | Glaxo Group Ltd | Vaccines |
| GB0304634D0 (en) * | 2003-02-28 | 2003-04-02 | Glaxo Group Ltd | Vaccines |
| GB0321615D0 (en) * | 2003-09-15 | 2003-10-15 | Glaxo Group Ltd | Improvements in vaccination |
| CA2954892A1 (fr) | 2016-01-19 | 2017-07-19 | Pfizer Inc. | Immunogenes derives d'antigenes associes a une tumeur ou des modules d'acide nucleique codant les immunogenes |
| CN106086050B (zh) * | 2016-06-28 | 2020-01-07 | 中国人民解放军第二军医大学 | 携带muc1肿瘤抗原表位pdtrp的嵌合型病毒样颗粒及在胰腺癌中的应用 |
| US11517591B2 (en) | 2017-09-01 | 2022-12-06 | Dana-Farber Cancer Institute, Inc. | Immunogenic peptides specific to BCMA and TACI antigens |
| CA3131138A1 (fr) | 2019-03-06 | 2020-09-10 | Dana-Farber Cancer Institute, Inc. | Recepteurs de lymphocytes t specifiques de l'antigene de maturation des lymphocytes b pour le traitement du cancer |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5695766A (en) * | 1992-10-30 | 1997-12-09 | Iowa State University Research Foundation | Highly virulent porcine reproductive and respiratory syndrome viruses which produce lesions in pigs and vaccines that protect pigs against said syndrome |
| US5744144A (en) * | 1993-07-30 | 1998-04-28 | University Of Pittsburgh University Patent Committee Policy And Procedures | Synthetic multiple tandem repeat mucin and mucin-like peptides, and uses thereof |
| AUPM322393A0 (en) * | 1993-12-24 | 1994-01-27 | Austin Research Institute, The | Mucin carbohydrate compounds and their use in immunotherapy |
| DE19516673A1 (de) * | 1995-04-28 | 1996-10-31 | Gabriele Dr Pecher | Vakzine gegen Tumorerkrankungen |
| AUPN568095A0 (en) * | 1995-09-27 | 1995-10-26 | Austin Research Institute, The | Anti-Galalpha(1,3)Gal antibody binding peptides |
| EP0923605A4 (fr) * | 1996-03-20 | 2003-01-02 | Sloan Kettering Inst Cancer | Vaccins conjugues contenant un peptide de mucine |
| US5744177A (en) * | 1996-06-11 | 1998-04-28 | Lin; Rong-Teng | Injection molding assembly |
-
1999
- 1999-12-22 GB GBGB9930359.6A patent/GB9930359D0/en not_active Ceased
-
2000
- 2000-12-20 EP EP00985646A patent/EP1240317B1/fr not_active Expired - Lifetime
- 2000-12-20 PL PL00356697A patent/PL356697A1/xx not_active Application Discontinuation
- 2000-12-20 IL IL15028500A patent/IL150285A0/xx unknown
- 2000-12-20 DE DE60033690T patent/DE60033690T2/de not_active Expired - Lifetime
- 2000-12-20 KR KR1020027008063A patent/KR20020073149A/ko not_active Application Discontinuation
- 2000-12-20 BR BR0016672-3A patent/BR0016672A/pt not_active IP Right Cessation
- 2000-12-20 CZ CZ20022192A patent/CZ20022192A3/cs unknown
- 2000-12-20 WO PCT/GB2000/004906 patent/WO2001046228A2/fr active IP Right Grant
- 2000-12-20 CN CN00819076A patent/CN1434862A/zh active Pending
- 2000-12-20 AT AT00985646T patent/ATE355365T1/de not_active IP Right Cessation
- 2000-12-20 AU AU22049/01A patent/AU2204901A/en not_active Abandoned
- 2000-12-20 NZ NZ519732A patent/NZ519732A/en unknown
- 2000-12-20 CA CA002395208A patent/CA2395208A1/fr not_active Abandoned
- 2000-12-20 MX MXPA02006313A patent/MXPA02006313A/es unknown
- 2000-12-20 JP JP2001547137A patent/JP2003517845A/ja active Pending
- 2000-12-20 HU HU0203848A patent/HUP0203848A3/hu unknown
- 2000-12-20 US US10/168,873 patent/US20030133909A1/en not_active Abandoned
- 2000-12-20 ES ES00985646T patent/ES2282156T3/es not_active Expired - Lifetime
-
2002
- 2002-06-20 ZA ZA200204987A patent/ZA200204987B/en unknown
- 2002-06-21 NO NO20023010A patent/NO20023010L/no not_active Application Discontinuation
-
2006
- 2006-11-02 US US11/555,793 patent/US20070269451A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CZ20022192A3 (cs) | 2002-11-13 |
| DE60033690D1 (de) | 2007-04-12 |
| CN1434862A (zh) | 2003-08-06 |
| EP1240317B1 (fr) | 2007-02-28 |
| ZA200204987B (en) | 2003-09-22 |
| HUP0203848A3 (en) | 2004-07-28 |
| KR20020073149A (ko) | 2002-09-19 |
| ATE355365T1 (de) | 2006-03-15 |
| EP1240317A2 (fr) | 2002-09-18 |
| PL356697A1 (en) | 2004-06-28 |
| AU2204901A (en) | 2001-07-03 |
| US20030133909A1 (en) | 2003-07-17 |
| MXPA02006313A (es) | 2002-11-29 |
| WO2001046228A3 (fr) | 2002-01-17 |
| WO2001046228A2 (fr) | 2001-06-28 |
| CA2395208A1 (fr) | 2001-06-28 |
| NO20023010D0 (no) | 2002-06-21 |
| DE60033690T2 (de) | 2007-11-08 |
| GB9930359D0 (en) | 2000-02-09 |
| NO20023010L (no) | 2002-08-06 |
| JP2003517845A (ja) | 2003-06-03 |
| NZ519732A (en) | 2004-03-26 |
| BR0016672A (pt) | 2002-10-08 |
| ES2282156T3 (es) | 2007-10-16 |
| US20070269451A1 (en) | 2007-11-22 |
| HUP0203848A2 (hu) | 2003-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1522579A3 (fr) | Gène de l'hyaluronan synthase et son utilisation | |
| DE60033138D1 (de) | Polypeptide mit galaktoseoxidaseaktivität und dafür kodierende nukleisäuren | |
| WO1998056927A3 (fr) | Acides nucleiques codant des polypeptides a fonction protease | |
| AU2002360331A1 (en) | Egviii endoglucanase and nucleic acids encoding the same | |
| CA2020668A1 (fr) | Proteines fusionnees ou hybrides comprenant de la lymphokine et un antigene viral | |
| DE69930955D1 (de) | Polypeptide mit lysophospholipaseaktivität und nukleinesäuren die sie kodieren | |
| EP0370458A3 (fr) | Antigènes à partir d'ADN synthétique dérivé du virus de l'immunodéficience humaine (HIV-1) recombinant | |
| CA2147124A1 (fr) | Analogues de l'erythropoietine | |
| EP0828003A3 (fr) | Sérine protéase humaine | |
| CA2437201A1 (fr) | Procedes et compositions utiles dans la stimulation d'une reponse immunitaire | |
| IL150285A0 (en) | Nucleic acid vaccination | |
| AU3802595A (en) | Tripeptidyl aminopeptidase | |
| AU577810B2 (en) | Cloning the gene for rabbit tumor necrosis factor polypeptide | |
| CA2281206A1 (fr) | Genes de geranyl diphosphate synthase | |
| WO1998042827A3 (fr) | Gene codant pour un oxalate decarboxylase isole a partir d'aspergillus phoenices | |
| AU7949991A (en) | Cloned n-methylhydantoinase | |
| AU7357294A (en) | Recombinant cladosporium herbarum allergens | |
| CA2128109A1 (fr) | Ameliorations du vaccin antipaludeen ou concernant ce vaccin | |
| WO1999031229A3 (fr) | Peptides et acides nucleiques derives d'eisenia foetida et leur utilisation | |
| WO1998024912A3 (fr) | Vaccin contre la peste obtenu par recombinaison | |
| WO2001040257A3 (fr) | Polypeptides cytokines et acides nucleiques | |
| WO2004003009A3 (fr) | Proteines immunogenes et adn les codant | |
| CA2244928A1 (fr) | Adn codant pour une serine/threonine-kinase | |
| AU7645400A (en) | Polypeptides having glucanotransferase activity and nucleic acids encoding same | |
| EP0863209A3 (fr) | Polyhydroxyalcanoate dépolymérase et procédé de sa production |